RxDoctor Payments Data

Douglas Cline

Queensbury, NYNPI 1619934858

Payments from drug & device makers

$2,271in general payments, 2019–2025

Across 154 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$480
  • Antares Pharma, Inc.$424
  • Pfizer$282
  • Vanda Pharmaceuticals Inc.$248
  • AbbVie$182
  • GRT US Holding, Inc.$84
  • plus $570 from 15 others

What the payments were for

  • Food & beverage$2,271100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl40$74,841
Fentanyl54$8,214
Oxycodone Hcl256$7,575
Morphine Sulfate ErMorphine Sulfate64$3,581
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen58$2,314
Methadone Hcl31$2,300
Gabapentin50$957
Morphine Sulfate18$860
Pregabalin24$346
Diazepam56$298
Carisoprodol22$260
Lactulose13$167
ConstuloseLactulose11$158
Celecoxib15$130
Meloxicam16$76

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →